Table 2.
CPS level and relevant comparison analyses of 36 head and neck SCC patients
| Median CPS (IQR) | p value | ||
|---|---|---|---|
| Cancer origin | Oral cavity | 8.8 (4.3–8.8) | 0.001* |
| Larynx | 0.8 (0.3–2.8) | ||
| Gender | Female | 14.9 (6.3–81.1) | 0.017* |
| Male | 2.7 (0.8–22.5) | ||
| Comorbidities | Comorbidities presence | 3.6 (0.8–8.8) | 0.0045* |
| No comorbidities | 30.6 (6.1–92.1) | ||
| Smoking habit | Smoking | 2.4 (0.5–6.3) | 0.021* |
| No smoking | 21 (3.8–81.1) | ||
| Disease stage | Stage 1 | 38.8 (5–100) | 0.2 |
| Stage 2 | 7.5 (2.4–22.6) | ||
| Stage 3 | 90 (2–100) | ||
| Stage 4 | 3.9 (0.8–21) | ||
| Survival | OS | 0.45 | |
| DFS | 0.31 | ||
| PFS | 0.88 | ||
*
Indicates a statistically significant difference.